Home > Insider Trading > Filing (0001628280-25-012826)

Filing Details

Accession Number:: 0001628280-25-012826
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-14 16:25:06
Reporting Period:: 2025-03-12

Filing Date:: 2025-03-14
Accepted Time:: 2025-03-14 16:25:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1157601	Madrigal Pharmaceuticals Inc.	MDGL	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1014095	B Fred Craves	C/O Bay City Capital Llc, 1000 4Th Street, Suite 500 San Rafael CA 94901		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-12	1,728	$65.06	351,804	No	4	M	Direct
Common Stock	Acquisiton	2025-03-12	6,000	$111.06	357,804	No	4	M	Direct
Common Stock	Disposition	2025-03-12	1,587	$330.54	356,217	No	4	S	Direct
Common Stock	Disposition	2025-03-12	2,759	$331.36	353,458	No	4	S	Direct
Common Stock	Disposition	2025-03-12	2,382	$332.38	351,076	No	4	S	Direct
Common Stock	Disposition	2025-03-12	800	$333.66	350,276	No	4	S	Direct
Common Stock	Disposition	2025-03-12	200	$334.97	350,076	No	4	S	Direct
Common Stock	Acquisiton	2025-03-13	7,742	$65.06	357,818	No	4	M	Direct
Common Stock	Disposition	2025-03-13	1,951	$322.45	355,867	No	4	S	Direct
Common Stock	Disposition	2025-03-13	1,649	$323.47	354,218	No	4	S	Direct
Common Stock	Disposition	2025-03-13	900	$324.69	353,318	No	4	S	Direct
Common Stock	Disposition	2025-03-13	800	$325.63	352,518	No	4	S	Direct
Common Stock	Disposition	2025-03-13	1,000	$327.63	351,518	No	4	S	Direct
Common Stock	Disposition	2025-03-13	400	$328.68	351,118	No	4	S	Direct
Common Stock	Disposition	2025-03-13	967	$329.86	350,151	No	4	S	Direct
Common Stock	Disposition	2025-03-13	75	$330.23	350,076	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2025-03-12	1,728	$0.00	1,728	$65.06
Common Stock	Stock Option (Right to Buy)	Disposition	2025-03-12	6,000	$0.00	6,000	$111.06
Common Stock	Stock Option (Right to Buy)	Disposition	2025-03-13	7,742	$0.00	7,742	$65.06

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,742	2025-06-16	No	4	M	Direct
0	2025-06-17	No	4	M	Direct
0	2025-06-16	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,210	Indirect	See Footnote
Common Stock	1,261	Indirect	See Footnotes
Common Stock	21,000	Indirect	See Footnotes

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.00 to $330.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.00 to $331.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.01 to $332.88, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.39 to $333.89, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.95 to $334.99, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.02 to $323.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $323.02 to $323.97, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $324.16 to $324.84, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $325.34 to $325.955, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.19 to $328.18, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.20 to $329.165, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.22 to $330.20, inclusive.
Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust.
These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.
Represents shares held indirectly by Dr. Craves through the Craves Family Foundation.
The shares underlying this stock option are fully vested and exercisable.